July - September 2012
July 18, 2012
Takeda Pharmaceutical Company Limited
Osaka, Japan, July 18, 2012 – Takeda Pharmaceutical Company Limited (“the Company”) announced today that the amount to be paid in exchange for Stock Acquisition Rights to be granted to its Directors and other related items were decided pursuant to the Subscription Requirements, etc., resolved by the board of directors meeting held on June 26, 2012.
The following is a notification of the specific terms.
|(2,678 yen per share)|
|Note:||On the allotment date, the Company shall make a consensual offset between the remuneration credits held by the Director toward the Company and the right to demand payment of the amount to be paid in for Stock Acquisition Rights.|